NEW YORK (GenomeWeb) – Quest Diagnostics today reported that its first quarter sales declined around 2 percent year over year with reimbursement issues and an "unseasonably harsh winter" cited as factors for the decrease.

The Madison, NJ-based clinical lab and diagnostic information services firm reported revenues from continuing operations of $1.75 billion, down from $1.79 billion in the first quarter of 2013. It matched the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.